Summary:
A 52-Week, Randomized, Double-Blind,
Placebo Controlled, Phase 3 Study to Evaluate the Effectiveness and Safety of
study drug in Adults with uncontrolled Asthma.
Qualified Participants Must:
• Be between 18 to 75 years of age
•
Have a diagnosis of Asthma for at least 12 months
•
Currently be on Asthma medications
•
Have had at least 2 Asthma exacerbations within the last 12 months
Qualified Participants May Receive:
Compensation for time and travel if qualified.